The use of a specific NLRP3 inhibitor has been noted to significantly protect mice from lethal influenza by reducing the BALF levels of proinflammatory cytokines, such as IL-1β and IL-18, and decreasing the recruitment of inflammatory cells into the lungs [27–29]. This evidence concerns the gene NLRP3 and influenza.